Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
115年第1季大陸投資
Regulatory Filings Classification · 90% confidence The document is a standardized disclosure of the company’s Mainland China investment details (capital invested, shareholding ratios, recognized gains, repatriated earnings) for the first quarter of the year. It is not a full financial report (Annual or Interim), nor an earnings release or management presentation. It is a regulatory filing required under the public information observation station without substantive narrative analysis. Therefore it belongs in the Regulatory Filings (RNS) category.
2026-05-14 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 80% confidence The text is a Taiwanese regulatory filing showing actual financial data for Q1 (“115年1季申報作業”)—a table of equity investments at period end. It contains substantive numbers for an interim period rather than being an announcement or summary only. This meets the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季財務報告書 — 202601_3716_AI1.pdf
Interim / Quarterly Report Classification · 96% confidence The document is titled "合併財務報告暨會計師核閱報告 民國115年及114年第一季" and includes full interim financial statements (consolidated balance sheet, income statement, cash flow, equity changes, notes) along with an auditor’s review report for the first quarter. It is a comprehensive interim/quarterly financial report, not merely an announcement or summary, matching the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-12 Chinese
第4次庫藏股基本資料
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding the company's share buyback program, including specifics such as the number of shares to be repurchased, the purpose of the buyback, board resolutions, pricing, and procedures for transferring repurchased shares to employees. It includes financial limits, dates, and regulatory compliance statements. This type of document is a report on the company's transaction in its own shares (share repurchase). It is not a general financial report, earnings release, or regulatory filing. The content matches the definition of a Transaction in Own Shares (POS) filing, which covers company buyback activities.
2026-05-06 Chinese
第4次庫藏股基本資料
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding the company's repurchase of its own shares, including specifics about the buyback plan, board resolutions, pricing, and procedures for transferring repurchased shares to employees. It includes data on the number of shares to be repurchased, price ranges, and regulatory compliance statements. This matches the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback activities. The document is not a brief announcement or a report publication notice, but a substantive disclosure of the buyback program details.
2026-05-05 Chinese
公告本公司董事會通過115年度第1季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (3716 中化控股) reporting the board's approval of the consolidated financial report for the first quarter of the fiscal year 115 (Taiwan calendar, corresponding to 2026). It includes detailed financial figures for the period 115/01/01 to 115/03/31, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is 909 characters long, which is relatively short but contains substantive financial data and analysis for a quarterly period. It is not merely an announcement that a report is published or attached, but the actual financial summary itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-05-05 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.